Reicin Alise is a director of Q32 Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Homology Medicines, Inc.
15 Jun 23
4
Sana Biotechnology, Inc.
9 Jun 23
4
Homology Medicines, Inc.
17 Jun 22
4
Sana Biotechnology, Inc.
8 Jun 22
4
Homology Medicines, Inc.
22 Jun 21
4/A
Sana Biotechnology, Inc.
18 Feb 21
4
Sana Biotechnology, Inc.
5 Feb 21
3
Sana Biotechnology, Inc.
3 Feb 21
4
Homology Medicines, Inc.
12 Jun 20
4
CELGENE CORP /DE/
22 Nov 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | QTTB Q32 Bio | Option Common Stock | Grant | Acquire A | No | No | 1.03 | 23,000 | 23.69 k | 23,000 |
8 Jun 23 | SANA Sana Biotechnology | Stock Option Common Stock | Grant | Acquire A | No | No | 6.7 | 65,000 | 435.50 k | 65,000 |